News Results for Puretech Health (PRTC)
-
30 Nov
06:05Director Deals - Puretech Health PLC (PRTC)Marjorie Scardino, Non Executive Director, bought 1,000 shares in the company on the 25th November 2020 at a price of $3.85. The Director now holds 788,710 shares. Story provided by...
-
24 Nov
13:45Vedanta Biosciences appoints Karuna Therapeutics' Ignelzi to board of directorsClinical-stage company Vedanta Biosciences has announced the appointment of Troy Ignelzi as an independent member to its board of directors. Vedanta is developing a new category of therapies for...
-
24 Nov
06:05Director Deals - Puretech Health PLC (PRTC)Robert Langer, Non Executive Director, has transferred out 308,876 shares in the company on the 28th October 2020 at a price of £0.00. The Director now holds 2,635,258 shares. Story provided by...
-
20 Nov
06:04Director Deals - Puretech Health PLC (PRTC)Christopher Viehbacher, Non Executive Director, bought 1,000 shares in the company on the 17th November 2020 at a price of $4.13. The Director now holds 1,029,516 shares. Story provided by...
-
20 Nov
06:04Director Deals - Puretech Health PLC (PRTC)Christopher Viehbacher, Non Executive Director, bought 5,000 shares in the company on the 17th November 2020 at a price of $4.14. The Director now holds 1,034,516 shares. Story provided by...
-
20 Nov
06:04Director Deals - Puretech Health PLC (PRTC)Christopher Viehbacher, Non Executive Director, bought 2,000 shares in the company on the 17th November 2020 at a price of $4.18. The Director now holds 1,041,516 shares. Story provided by...
-
20 Nov
06:04Director Deals - Puretech Health PLC (PRTC)Christopher Viehbacher, Non Executive Director, bought 5,000 shares in the company on the 17th November 2020 at a price of $4.15. The Director now holds 1,039,516 shares. Story provided by...
-
20 Nov
06:04Director Deals - Puretech Health PLC (PRTC)Christopher Viehbacher, Non Executive Director, bought 3,130 shares in the company on the 17th November 2020 at a price of $4.16. The Director now holds 1,045,646 shares. Story provided by...
-
20 Nov
06:04Director Deals - Puretech Health PLC (PRTC)Christopher Viehbacher, Non Executive Director, bought 1,000 shares in the company on the 17th November 2020 at a price of $4.16. The Director now holds 1,042,516 shares. Story provided by...
-
20 Nov
06:04Director Deals - Puretech Health PLC (PRTC)Christopher Viehbacher, Non Executive Director, bought 2,870 shares in the company on the 17th November 2020 at a price of $4.13. The Director now holds 1,028,516 shares. Story provided by...
-
18 Nov
09:57PureTech Health releases positive early study results for inflamation treatmentClinical-stage biotherapeutics company PureTech Health said it had completed a first-phase study for a potential treatment of conditions involving inflammation and fibrosis and disorders of...
-
13 Nov
11:51FTSE on course for very strong week despite modest intra-day fallApproaching midday the FTSE 100 was down 0.4% to 6,310.79, off its low point for the day and still on course for a strong week overall. Other European markets were in mildly positive territory...
-
13 Nov
08:56UK markets dip; Galliford Try gainsUK markets have opened lower as Prime Minister Boris Johnson's senior adviser Dominic Cummings announced he is set to leave his role by Christmas. Meanwhile, in the US, election officials have...
-
13 Nov
07:14PureTech Health to start trading on Nasdaq on 16 NovemberBiotherapeutics company PureTech Health has said it expects trading of American depository shares (ADSs) of the company on Nasdaq to commence on Monday, 16 November 2020 under the ticker symbol...
-
11 Nov
13:11PureTech Health subsid licenses clinical-stage cancer treatmentPureTech Heath founded entity Vor has entered an exclusive licensing agreement with the National Cancer Institute. This agreement covers the group's intellectual property related to clinical...
-
03 Nov
15:12Director Deals - Puretech Health PLC (PRTC)John Lamattina, Non Executive Director, has transferred in 305,296 shares in the company on the 29th October 2020 at a price of £0.00. The Director now holds 1,512,733 shares. Story provided by...
-
03 Nov
15:12Director Deals - Puretech Health PLC (PRTC)John Lamattina, Non Executive Director, has transferred out 305,296 shares in the company on the 29th October 2020 at a price of £0.00. The Director now holds 1,207,437 shares. Story provided by...
-
28 Oct
07:14PureTech Health files registration statement for US listingBiotherapeutics company PureTech Health said it had filed a registration statement to list American depository shares on the Nasdaq stock market in the US. PureTech Health said the US listed was...
-
21 Oct
14:24PureTech Health welcomes presentation of ADHD treatment trial resultsBiotherapeutics company PureTech Health welcomed news that founded entity Akili had presented positive data related to the trial of a digital-based treatment for attention-deficit/hyperactivity...
-
20 Oct
13:23PureTech Health founded entity Vor appoints Matthew Patterson to boardBiotherapeutics company PureTech Health said founded entity and oncology company Vor Biopharma had appointed Matthew R Patterson to its board. Patterson was co-founder of Audentes Therapeutics and...
-
05 Oct
13:04PureTech Health founded entity Alivio gets $3.3m US grant for IBS treatmentBiotherapeutics company PureTech Health welcomed news that founded entity Alivio Therapeutics had awarded $3.3 million from US Department of Defense to advance a potential treatment for...
-
23 Sep
07:24PureTech Health applies for US listingClinical-stage biotherapeutics company PureTech Health said it had filed a registration statement with US regulators for a planned listing on the Nasdaq. The company said the US listing would not...
-
16 Sep
13:09PureTech Health founded entity Vedanta appoints chief medical officerBiotherapeutics company PureTech Health said founded entity Vedanta Biosciences had appointed Jeffrey Silber as its chief medical officer. Silber had previously worked at Merck, AbbVie and EMD...
-
04 Sep
13:11PureTech Health founded entity Gelesis presents positive trial resultsPureTech Health said founded entity Gelesis would deliver oral and poster presentations displaying efficacy data for a weight loss treatment at the European and International Congress on Obesity....
-
27 Aug
07:57PureTech income soars after regulatory approvals and subsidiary salesBiotechnology company PureTech Health generated $245m of cash in the first half of 2020 through the sales of stakes in subsidiaries. Its H1 income after tax of $123.7m was nearly four times the...
-
26 Aug
13:16PureTech Health sells part of Karuna Therapeutics stake for around $100mBiotherapeutics company PureTech Health said it had sold part of its stake in founded entity and central nervous system disorder focused Karuna Therapeutics for around $100m. PureTech said it...
-
25 Aug
14:22PureTech Health welcomes Sonde Health acquisition of NeuroLex LaboratoriesBiotherapeutics company PureTech Health welcomed news that founded Entity Sonde Health had acquired voice-enabled survey and data acquisition platform NeuroLex Laboratories, for an undisclosed...
-
29 Jul
09:20Broker Forecast - Liberum Capital issues a broker note on PureTech Health PlcLiberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 490p (from 450p). Story provided by StockMarketWire.com Broker Forecasts...
-
14 Jul
14:37PureTech Health founded entity Vor Biopharma appoints chief medical officerBiotherapeutics company PureTech Health welcomed news that founded entity Vor and oncology company Biopharma had appointed Christopher Slapak as its chief medical officer. Slapak previously led...
-
08 Jul
14:36PureTech Healthy company Sonde launches voice-based Covid-19 detection appBiotherapeutics company PureTech Health welcomed news that founded entity Sonde Health had launched an app designed to detect respiratory diseases such as Covid-19 by monitoring voice recordings....
-
07 Jul
13:12PureTech Health founded company Vor raises $110mClinical-stage biotherapeutics company PureTech Health welcomed news that founded entity Vor Biopharma had raised $110m of financing. Vor was developing engineered haematopoietic stem cell...
-
23 Jun
07:19PureTech Health founded company Akili gets CE mark for digital ADHD treatmentBiotherapeutics company PureTech Health welcomed news that founded entity Akili had received a CE mark for its digital-based treatment for attention deficit hyperactivity disorder. The EndeavorRx...
-
16 Jun
08:42UK stocks open 2.5% stronger as Fed jacks up stimulusUK stocks opened substantially higher on Tuesday after the US Federal Reserve announced more fiscal stimulus to buffer the world's biggest economy from the Covid-19 crisis. At 0827, the benchmark...
-
16 Jun
07:14PureTech Health company Akili gets FDA clearance for digital ADHD treatmentBiotherapeutics company PureTech Health said founded entity Akili had received US regulatory approval for a digital-based treatment for attention-deficit/hyperactivity disorder. Clearance for use...
-
04 Jun
08:06PureTech Health receives positive feedback from FDA for hair loss treatment Follica; 'pivotal trial' this yearBiotherapeutics company PureTech Health has said that Follica, which it founded, has received positive feedback from the US Food and Drug Administration (FDA) as it prepares to advance its lead...
-
02 Jun
16:34FTSE end higherUK stocks rallied on Tuesday as hopes of an economic revival sparked by an easing Covid-19 lockdowns were tempered by persistent rioting in the US. At 16:30, the benchmark FTSE 100 index was 0.9%...
-
02 Jun
12:04FTSE holds on to gains at middayUK stocks held on to early gains at midday Tuesday as hopes of an economic revival sparked by an easing Covid-19 lockdowns were tempered by persistent rioting in the US. At 12:00, the benchmark...
-
02 Jun
07:36PureTech Health company Gelesis approved to sell weight loss treatment in EuropeBiotherapeutics company PureTech Health said its Gelesis unit, which it founded, had received approval to market a novel weight loss treatment in Europe. Gelesis had received a CE mark for the...
-
28 May
08:23PureTech Health plans global trial in Q3 for potential treatment of COVID-19 post-recovery complicationsClinical stage biotherapeutics company PureTech Health has announced plans to advance its product candidate LYT-100 (deupirfenidone) as a potential treatment for serious respiratory complications...
-
21 May
14:00Director Deals - PureTech Health Plc (PRTC)Dr John LaMattina, Non Executive Director, bought 6,700 shares in the company on the 20th May 2020 at a price of 250.00p. The Director now holds 1,512,283 shares. Story provided by...
-
20 May
11:35Director Deals - PureTech Health Plc (PRTC)Dr John LaMattina, Non Executive Director, bought 8,201 shares in the company on the 18th May 2020 at a price of 246.00p. The Director now holds 1,505,583 shares. NOTE: pca Story provided by...
-
19 May
10:00Director Deals - PureTech Health Plc (PRTC)Dr John LaMattina, Non Executive Director, bought 1,500 shares in the company on the 15th May 2020 at a price of 232.00p. The Director now holds 1,497,382 shares. NOTE: PCA Story provided by...
-
18 May
13:30Director Deals - PureTech Health Plc (PRTC)Dr John LaMattina, Non Executive Director, bought 1,000 shares in the company on the 14th May 2020 at a price of 220.00p. The Director now holds 1,496,332 shares. NOTE: average price. PCA Story...
-
09 Apr
09:37PureTech Health boosts wholly owned pipeline in 2019; says Covid-19 may eventually impact timelinesClinical stage biotherapeutics company PureTech Health has reported a strong capital base with $321.5m in pro-forma cash in its annual results to 31 December 2019 and confirmed the growth of its...
-
03 Mar
07:45PureTech Health doses first patient in lymphoedema treatment studySerious disease focused PureTech Health said the first participant had been dosed in a clinical study of a treatment for lymphoedema and other fibrotic conditions. PureTech Health said there was...
-
25 Feb
09:33PureTech Health welcomes publication of ADHD treatment trial resultsPureTech Health welcomed news that affiliate company Akili had published positive trial results for a treatment for attention-deficit/hyperactivity disorder in The Lancet Digital Health journal....
-
24 Jan
10:20Broker Forecast - Liberum Capital issues a broker note on PureTech Health PlcLiberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 450p (from 420p). Story provided by StockMarketWire.com Broker Forecasts...
-
23 Jan
07:15PureTech sells minority shares in KarunaClinical stage biotech company, PureTech Health, has announced it has sold 2.1 million shares of its affiliate, Karuna Therapeutics. The cash sale has generated approximately $200 million which...
-
13 Jan
11:20Broker Forecast - Liberum Capital issues a broker note on PureTech Health PlcLiberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and cut its price target to 420p (from 450p). Story provided by StockMarketWire.com Broker Forecasts...
-
19 Dec
09:37PureTech Health affiliate Follica reveals positive androgenetic alopecia studyBiotechnology company PureTech Health's affiliate Follica has announced topline results from its safety and efficacy optimisation study to treat hair loss in male androgenetic alopecia. In a...
-
17 Dec
13:12PureTech Health affiliate Gelesis partners with telehealth provider RoPureTech Health said affiliate company Gelesis was partnering with US telehealth provider Ro to offer remote care dedicated to weight management. The pact would involve the distribution of...
-
10 Dec
07:31PureTech Health affiliate Vedanta Biosciences starts cancer treatment trialBiotechnology company PureTech Health said affiliate Vedanta Biosciences had initiated a clinical study regarding an immuno-oncology candidate in patients with types of advanced or metastatic...
-
09 Dec
16:36UK stocks close slightly downUK stocks traded slightly lower Monday, following the release of weak Chinese export data that offset positive sentiment inspired by strong US jobs numbers released Friday. At 16:00, the benchmark...
-
09 Dec
09:00UK stocks open 0.1% lower as Chinese exports fallUK stocks opened a little lower on Monday following the release of weak Chinese export data that offset positive sentiment inspired by strong US jobs numbers released Friday. At 0844, the...
-
09 Dec
07:32PureTech Health affiliate Gelesis raises $84.6mPureTech Health said affiliate company and obesity treatment developer Gelesis had raised $84.6m to fund the launch of a key product. The raising included equity funding of $63.4m, led by private...
-
05 Dec
07:33PureTech Health affiliate Vedanta Biosciences granted $5.8m for multi-drug resistance programClinical stage biotechnology company PureTech Health has announced its affiliate, Vedanta Biosciences, has been awarded a $5.8m grant for its VE707 programme targeting multi-drug resistant...
-
22 Nov
08:10Broker Forecast - Peel Hunt issues a broker note on PureTech Health PlcPeel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 460p (from 380p). Story provided by StockMarketWire.com Broker Forecasts data...
-
20 Nov
08:30Broker Forecast - Liberum Capital issues a broker note on PureTech Health PlcLiberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 450p (from 300p). Story provided by StockMarketWire.com Broker Forecasts...
-
18 Nov
16:45FTSE inches ahead despite fresh trade fearsUK stocks finished lower on Monday after a report stoked fresh fears about a resolution to the US-China trade dispute that has hit global growth. A headwind for the FTSE 100 was a strengthening of...
-
18 Nov
13:01PureTech Health welcomes positive study results for schizophrenia treatmentPureTech Health noted that affiliate company Karuna Therapeutics met its primary goal in a clinical trial of a treatment of acute psychosis in patients with schizophrenia. The treatment, called,...
-
15 Nov
14:22PureTech Health notes disappointing trial results posted by affiliate company resTORbioPureTech Health noted that independent affiliate resTORbio had announced disappointing data from a study evaluating the safety and efficacy of a treatment for clinically symptomatic respiratory...
-
24 Oct
09:50PureTech Health announces Sonde Health CEO appointmentPureTech Health affiliate Sonde Health has appointed David Liu as chief executive and a member of its board of directors. The appointment follows the recently announced $16m Series A financing...
-
02 Oct
07:53PureTech acquires remaining 10% of Ariya TherapeuticsBrain-gut axis treatment developer PureTech Health said it had acquired the remaining 10% of Ariya Therapeutics that it did not already own. The company had been renamed LYT and would its four...
-
27 Aug
08:10Broker Forecast - Liberum Capital issues a broker note on PureTech Health PlcLiberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 347p (from 336p). Story provided by StockMarketWire.com Broker Forecasts...
-
27 Aug
07:22PureTech Health losses widen on higher R&D spending, tax chargeClinical stage biotechnology company PureTech Health booked a first-half loss after a gain in the value of its investments was offset by a higher tax charge and steeper R&D spending. Net...
-
07 Aug
14:23Robert Ang to head PureTech Health affiliate Vor BiopharmaBiopharmaceutical company PureTech Health said affiliate Vor Biopharma had appointed Robert Ang as its chief executive. Ang joined from Neon Therapeutics, where he served as chief business...
-
19 Jul
08:10Broker Forecast - Peel Hunt issues a broker note on PureTech Health PlcPeel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 380p (from 344p). Story provided by StockMarketWire.com Broker Forecasts data...
-
17 Jul
08:23PureTech Health acquires new product candidate for lymphatic diseasesPureTech Health said it had acquired a clinical-stage product candidate for the potential treatment of lymphatic and immunofibrotic diseases, including lymphedema. In preclinical studies, the...
-
11 Jul
08:05PureTech Health mulls US listingBiopharmaceutical company PureTech Health said it was "exploring the potential" for a listing on the Nasdaq stock exchange in the United States. The US listing would be expected to include an...
-
09 Jul
09:36PureTech Health issued with US patent for immuno-oncology candidatePureTech Health said it had been issued with a patent in the US that supported an immuno-oncology product candidate. The US Patent and Trademark Office had issued US Patent No. 10,344,091 to...
-
02 Jul
10:50Broker Forecast - Liberum Capital issues a broker note on PureTech Health PlcLiberum Capital today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 336p (from 308p). Story provided by StockMarketWire.com Broker Forecasts...
-
20 Jun
07:46Puretech unveils new HQPureTech Health, a biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, today announced a new corporate headquarters and labs in Boston's...
-
03 Jun
08:08PureTech Health affiliate Karuna Therapeutics files for IPOPureTech Health said that affiliate Karuna Therapeutics had filed for a proposed initial public offering of shares in the US. The number of shares to be offered and the price range for the...
-
29 May
08:23PureTech Health affiliate Vor Biopharma publishes key scientific paperPureTech Health said affiliate Vor Biopharma had announced the publication of a paper in a scientific journal supporting its approach to treating cancer via engineered hematopoietic stem cells....
-
13 May
07:56PureTech Health affiliate Vedanta Biosciences notches $18.5m financing extensionPureTech Health said affiliate Vedanta Biosciences had announced an $18.5m extension of a financing round, bringing the total for the round to $45.5m. The new investment came from JSR Corporation,...
-
25 Apr
09:31PureTech Health affiliate Gelesis receives $10.6m grant for first productBiopharmaceutical company PureTech Health has announced that its affiliate Gelesis has received a $10.6m grant to support the commercial manufacturing of its first product, Plenity. The company...
-
24 Apr
09:31PureTech Health posts annual loss owing to treatment development spendingPureTech Health, which develops treatments for 'dysfunctions of the brain-immune-gut axis', booked an full-year loss as it ramped up R&D spending. Pre-tax losses for the year through December...
-
15 Apr
08:26PureTech Health affiliate Gelesis gets FDA nod for weight management productPureTech Health said affiliate Gelesis had received marketing clearance from the FDA for a weight management product. The orally-administered hydrogel was designed to absorb water and increase the...
-
15 Apr
08:00Broker Forecast - Peel Hunt issues a broker note on PureTech Health PlcPeel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 344p (from 320p). Story provided by StockMarketWire.com Broker Forecasts data...
-
11 Apr
09:47PureTech's Sonde Health completes $16m financing for vocal biomarker screening techPureTech affiliate Sonde Health announced it had completed a $16m Series A financing round to advance Sonde's vocal biomarker technology. The proceeds from the financing would be used to progress...
-
18 Mar
09:28PureTech Health affiliate Karuna Therapeutics raises $68mPureTech Health said affiliate Karuna Therapeutics had completed a $68m financing round. The series B financing included the issuance of $5m in shares upon conversion of debt into equity....
-
12 Mar
09:10Broker Forecast - Peel Hunt issues a broker note on PureTech Health PlcPeel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 320p (from 313p). Story provided by StockMarketWire.com Broker Forecasts data...
-
04 Jan
08:20Broker Forecast - Jefferies International issues a broker note on PureTech Health PlcJefferies International today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 255p (from 245p). Story provided by StockMarketWire.com Broker...
-
17 Dec
07:45PureTech Health affiliate Vedanta Biosciences kicks of clinical studyPureTech Health said its Vedanta Biosciences unit had commenced a clinical study of a treatment for the Clostridium difficile bowel infection. The phase-two study of the treatment, VE303, was...
-
10 Dec
09:15PureTech Health affiliate Vedanta Biosciences teams up with Bristol-Myers SquibbPureTech Health noted that affiliate company Vedanta Biosciences had entered into a collaboration with Bristol-Myers Squibb. The companies had agreed to to evaluate Vedanta's microbiome-derived...
-
06 Nov
13:37PureTech Health unit Vedanta Biosciences releases positive treatment dataPureTech Health said subsidiary Vedanta Biosciences had released data showing that a product candidate had induced an anti-tumour response. The treatment, VE800, is an orally-administered, live...
-
15 Oct
08:20PureTech Health affiliate Karuna commences study for new schizophrenia treatmentPureTech Health said affiliate company Karuna Pharmaceuticals had started a key study for a treatment for psychosis in schizophrenia. The so-called Phase 2 study would test least product candidate...
-
04 Oct
09:43PureTech's Vedanta Biosciences announce successful Phase1a/1b VE303 clinical studyThe Vedanta Biosciences arm of biopharma company PureTech announced that preliminary results from its Phase 1a/1b clinical study of its live biotherapeutic product VE303 demonstrated safety,...
-
20 Jul
16:55FTSE dips on potential trade war escalationThe FTSE 100 remained in the red after US President Donald Trump threatened to impose tariffs on all imports for China. The blue-chip index was 5.1 points lower at 7,678. Miners were among the...
-
20 Jul
12:01FTSE hit by latest Trump threatThe FTSE 100 struggled on Friday with earlier gains wiped out in late morning trading thanks to the broadcast of a news interview where Donald Trump threatened to put tariffs on all Chinese...
-
20 Jul
07:49PureTech Health inks collaboration pact with RochePureTech Health said it had entered into a multi-year collaboration with Roche to advance PureTech's milk-derived exosome platform technology. The technology would be applied to assist in the oral...
-
09 May
12:00Broker Forecast - Jefferies International issues a broker note on PureTech Health PlcJefferies International today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and set its price target at 245p. Story provided by StockMarketWire.com Broker Forecasts data...
-
09 May
10:40Broker Forecast - Peel Hunt issues a broker note on PureTech Health PlcPeel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and set its price target at 313p. Story provided by StockMarketWire.com Broker Forecasts data provided by...
-
16 Apr
08:09PureTech Health operating losses deepen on higher R&D spendBiopharmaceutical group PureTech Health said annual operating losses deepened as revenue fell and it continued to study treatments for ADHD and obesity. The company is still in product development...
-
09 Apr
07:14PureTech Health affiliate appoints new CEOCommense, an affiliate of PureTech Health, announced the appointment of Edward J "Tad" Stewart as President and Chief Executive Officer. Mr Stewart will focus on advancing Commense's lead program...
-
15 Mar
09:00Director Deals - PureTech Health Plc (PRTC)Dr John LaMattina, Non Executive Director, bought 43,000 shares in the company on the 14th March 2018 at a price of 163.00p. The Director now holds 1,495,332 shares. NOTE: Connected Trust Story...
-
14 Mar
10:15Director Deals - PureTech Health Plc (PRTC)Dr Robert Langer, Non Executive Director, bought 4,300 shares in the company on the 13th March 2018 at a price of 162.00p. The Director now holds 2,944,134 shares. Story provided by...
-
26 Jan
10:40Broker Forecast - Peel Hunt issues a broker note on PureTech Health PlcPeel Hunt today reaffirms its buy investment rating on PureTech Health Plc (LON:PRTC) and raised its price target to 313p (from 302p). Story provided by StockMarketWire.com
-
26 Jan
07:18PureTech affiliate resTORbio prices $85.0m IPOPureTech Health said affiliate company resTORbio has a priced its initial public offering on the Nasdaq exchange. Shares would be issued at an offer price of $15.00 each, resulting in gross...
-
03 Jan
09:14PureTech affiliate appoints new directorPureTech Health said affiliate company resTORbio has appointed Lynne Sullivan as a new independent director. Sullivan is currently senior vice president of finance at Biogen. At 9:14am:...